[HTML][HTML] Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma
A Méjean, A Ravaud, S Thezenas… - … England Journal of …, 2018 - Mass Medical Soc
Background Cytoreductive nephrectomy has been the standard of care in metastatic renal-
cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies …
cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies …
[PDF][PDF] Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
A Méjean, A Ravaud, S Thezenas, S Colas… - N Engl J …, 2018 - amedeolucente.it
BACKGROUND Cytoreductive nephrectomy has been the standard of care in metastatic
renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective …
renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective …
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
A Méjean, A Ravaud, S Thezenas, S Colas… - New England Journal …, 2018 - cir.nii.ac.jp
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
A Mejean, A Ravaud, S Thezenas, S Colas… - New England Journal …, 2018 - hal.science
BACKGROUND Cytoreductive nephrectomy has been the standard of care in metastatic
renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective …
renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective …
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
A Mejean, A Ravaud, S Thezenas, S Colas… - New England Journal …, 2018 - amu.hal.science
BACKGROUND Cytoreductive nephrectomy has been the standard of care in metastatic
renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective …
renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective …
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
A Méjean, A Ravaud, S Thezenas… - The New England …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Cytoreductive nephrectomy has been the standard of care in metastatic renal-
cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies …
cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies …
[PDF][PDF] Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
A Méjean, A Ravaud, S Thezenas, S Colas… - 2018 - med-fom-urlgsci.sites.olt.ubc.ca
BACKGROUND Cytoreductive nephrectomy has been the standard of care in metastatic
renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective …
renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective …
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
A Méjean, A Ravaud, S Thezenas… - The New England …, 2018 - mpgjournal.mpg.es
Background Cytoreductive nephrectomy has been the standard of care in metastatic renal-
cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies …
cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies …
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
A Méjean, A Ravaud, S Thezenas, S Colas… - The New England …, 2018 - europepmc.org
Background Cytoreductive nephrectomy has been the standard of care in metastatic renal-
cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies …
cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies …
[PDF][PDF] Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
A Méjean, A Ravaud, S Thezenas, S Colas… - N Engl J …, 2018 - amedeolucente.it
BACKGROUND Cytoreductive nephrectomy has been the standard of care in metastatic
renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective …
renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective …